Daré Bioscience, Inc.
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Daré Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on women’s health. Daré Bioscience develops and commercializes therapies in contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health, with an emphasis on improving treatment options and convenience for women. Its portfolio includes approved and investigational products designed to address unmet needs in reproductive and intimate health, such as non-hormonal contraception, vaginal health treatments, and hormone-related therapies. The company operates as a product-driven biotech business, advancing candidates through clinical development and regulatory pathways in the United States. Headquartered in San Diego, California, Daré Bioscience plays a specialized role in the healthcare market by concentrating on differentiated solutions for areas that are often underrepresented in women’s medicine.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Sabrina Martucci Johnson
- Employees
- 21
- Headquarters
- San Diego, CA, United States
- Website
- darebioscience.com